Tumor-infiltrating pDCs display an impaired response to TLR7/9 activation and decreased or defective production of type I IFN, and contribute to the establishment of an immunosuppressive tumor microenvironment through high expression of PD-L1 and IDO (36, 41). This evidence concerns the gene CD274 and neoplasm.